Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Ventas Inc. Common Stock (VTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Ventas Inc. Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.64 (market cap $2.27B), while Ventas Inc. Common Stock trades at $82.23 (market cap $41.94B). The key difference: Ventas Inc. Common Stock is far larger — about 18.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Ventas Inc. Common Stock pays a 2.54% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | VTR | |
|---|---|---|
Market Cap | $2.27B | $41.94B |
Volume | 4,179,659 | 4,588,793 |
Sector | Health | Real Estate |
52-Week High | $15.46 | $100.53 |
52-Week Low | $1.39 | $67.45 |
Enterprise Value | $2.14B | $54.66B |
Typical Hold Time | — | 1 Days |
Dividend Yield | — | 2.54% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Ventas Inc. Common Stock
Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →
